Literature DB >> 33326237

Isolation and Pharmacological Characterization of Six Opioidergic Picralima nitida Alkaloids.

Simone M Creed1, Anna M Gutridge2, Malaika D Argade1, Madeline R Hennessy1, J Brent Friesen3, Guido F Pauli3, Richard M van Rijn4, Andrew P Riley1.   

Abstract

The seeds of the akuamma tree (Picralima nitida) have been used as a traditional treatment for pain and fever. Previous studies have attributed these effects to a series of indole alkaloids found within the seed extracts; however, these pharmacological studies were significantly limited in scope. Herein, an isolation protocol employing pH-zone-refining countercurrent chromatography was developed to provide six of the akuamma alkaloids in high purity and quantities sufficient for more extensive biological evaluation. Five of these alkaloids, akuammine (1), pseudo-akuammigine (3), akuammicine (4), akuammiline (5), and picraline (6), were evaluated against a panel of >40 central nervous system receptors to identify that their primary targets are the opioid receptors. Detailed in vitro investigations revealed 4 to be a potent kappa opioid receptor agonist, and three alkaloids (1-3) were shown to have micromolar activity at the mu opioid receptor. The mu opioid receptor agonists were further evaluated for analgesic properties but demonstrated limited efficacy in assays of thermal nociception. These findings contradict previous reports of the antinociceptive properties of the P. nitida alkaloids and the traditional use of akuamma seeds as analgesics. Nevertheless, their opioid-preferring activity does suggest the akuamma alkaloids provide distinct scaffolds from which novel opioids with unique pharmacologic properties and therapeutic utility can be developed.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33326237      PMCID: PMC7932029          DOI: 10.1021/acs.jnatprod.0c01036

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  31 in total

Review 1.  Treatment of chronic non-cancer pain.

Authors:  Dennis C Turk; Hilary D Wilson; Alex Cahana
Journal:  Lancet       Date:  2011-06-25       Impact factor: 79.321

2.  Natural products as a perspective for cancer pain management: A systematic review.

Authors:  Daniele Nascimento Gouveia; Adriana Gibara Guimarães; Wagner Barbosa da Rocha Santos; Lucindo José Quintans-Júnior
Journal:  Phytomedicine       Date:  2018-11-22       Impact factor: 5.340

3.  Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019.

Authors:  David J Newman; Gordon M Cragg
Journal:  J Nat Prod       Date:  2020-03-12       Impact factor: 4.050

4.  Pain as a global public health priority.

Authors:  Daniel S Goldberg; Summer J McGee
Journal:  BMC Public Health       Date:  2011-10-06       Impact factor: 3.295

5.  Pseudo-akuammigine, an alkaloid from Picralima nitida seeds, has anti-inflammatory and analgesic actions in rats.

Authors:  M Duwiejua; E Woode; D D Obiri
Journal:  J Ethnopharmacol       Date:  2002-06       Impact factor: 4.360

6.  Opioid activity of alkaloids extracted from Picralima nitida (fam. Apocynaceae).

Authors:  J R Menzies; S J Paterson; M Duwiejua; A D Corbett
Journal:  Eur J Pharmacol       Date:  1998-05-29       Impact factor: 4.432

7.  Large-scale separation of alkaloids from Gelsemium elegans by pH-zone-refining counter-current chromatography with a new solvent system screening method.

Authors:  Lei Fang; Jie Zhou; YunLiang Lin; Xiao Wang; Qinglei Sun; Jia-Lian Li; Luqi Huang
Journal:  J Chromatogr A       Date:  2013-07-23       Impact factor: 4.759

8.  Residual Complexity Does Impact Organic Chemistry and Drug Discovery: The Case of Rufomyazine and Rufomycin.

Authors:  Mary P Choules; Larry L Klein; David C Lankin; James B McAlpine; Sang-Hyun Cho; Jinhua Cheng; Hanki Lee; Joo-Won Suh; Birgit U Jaki; Scott G Franzblau; Guido F Pauli
Journal:  J Org Chem       Date:  2018-05-24       Impact factor: 4.354

9.  G protein-biased kratom-alkaloids and synthetic carfentanil-amide opioids as potential treatments for alcohol use disorder.

Authors:  Anna M Gutridge; Meridith T Robins; Robert J Cassell; Rajendra Uprety; Kendall L Mores; Mee Jung Ko; Gavril W Pasternak; Susruta Majumdar; Richard M van Rijn
Journal:  Br J Pharmacol       Date:  2020-01-24       Impact factor: 8.739

10.  Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018.

Authors:  Nana Wilson; Mbabazi Kariisa; Puja Seth; Herschel Smith; Nicole L Davis
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-03-20       Impact factor: 17.586

View more
  3 in total

1.  Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator Capabilities.

Authors:  Yazan J Meqbil; Hongyu Su; Robert J Cassell; Kendall L Mores; Anna M Gutridge; Benjamin R Cummins; Lan Chen; Richard M van Rijn
Journal:  Molecules       Date:  2021-11-29       Impact factor: 4.927

2.  Evaluation of Kratom Opioid Derivatives as Potential Treatment Option for Alcohol Use Disorder.

Authors:  Anna M Gutridge; Soumen Chakraborty; Balazs R Varga; Elizabeth S Rhoda; Alexander R French; Arryn T Blaine; Quinten H Royer; Haoyue Cui; Jinling Yuan; Robert J Cassell; Márk Szabó; Susruta Majumdar; Richard M van Rijn
Journal:  Front Pharmacol       Date:  2021-11-03       Impact factor: 5.988

Review 3.  An insight into the recent developments in anti-infective potential of indole and associated hybrids.

Authors:  Basavarajaiah Suliphuldevara Mathada; Sasidhar B Somappa
Journal:  J Mol Struct       Date:  2022-03-11       Impact factor: 3.841

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.